The proteome profile of two cell lines and their xenografts isolated from a patient with clear cell sarcoma (soft tissue melanoma)

Cancer Genomics and Proteomics

Volumn 5, Issue 3-4, 2008, Pages 175-238

  Dimas, Konstantinos ^a   Tsimplouli, Chrisiida ^a   Anagnostopoulos, Athanassios K ^a   Mahaira, Louisa ^a,b   Iliopoulou, Eleni ^c   Perez, Sonia ^c   Vougas, Konstantinos ^a   Tsangaris, George T ^a  

^a BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^b Anavex Life Science   (Greece)

^c SAINT SAVVAS HOSPITAL   (Greece)

Author keywords

2 DE protein database; Cell lines; Clear cell sarcoma; MALDI MS; Malignant melanoma; Mass spectrometry; Proteomics; Soft tissue melanoma; Xenografts

Indexed keywords

GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; NESTIN; PROTEIN CLC11; PROTEIN P53; PROTEIN S 100; PROTEOME; TRYPSIN; VIMENTIN;

ADULT; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; CANCER RESEARCH; CANCER THERAPY; CELL LINE; CLEAR CELL SARCOMA; COMPARATIVE STUDY; HUMAN; HUMAN CELL; MALE; MALIGNANT NEOPLASTIC DISEASE; MASS SPECTROMETER; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MELANOMA; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; ONCOGENE; PEPTIDE MASS FINGERPRINT; POST SOURCE DECAY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; SCID MOUSE; SOFT TISSUE; TECHNIQUE; TREATMENT PLANNING; TWO DIMENSIONAL GEL ELECTROPHORESIS; UNINDEXED SEQUENCE; XENOGRAFT; XENOTRANSPLANTATION;

MUS;

ANIMALS; CELL LINE, TUMOR; HUMANS; MALE; MICE; MICE, INBRED NOD; MICE, SCID; MIDDLE AGED; PROTEOME; SARCOMA, CLEAR CELL; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRANSPLANTATION, HETEROLOGOUS;

EID: 46849114927     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. de Vries E and Goebergh JW: Cutaneous malignant melanoma in Europe. Eur J Cancer 40: 2355-2366, 2004.
2. de Vries E and Goebergh JW: Melanoma incidence has risen in Europe. BMJ 331: 698, 2005.
3. Bordeaux JS, Lu KQ and Cooper KD: Melanoma: prevention and early detection. Semin Oncol 34: 460-466, 2007.
4. Tawbi HA and Kirkwood JM: Management of metastatic melanoma. Semin Oncol 34: 532-545, 2007.
5. Meis-Kindblom JM: Clear cell sarcoma of tendons and aponeuroses: a historical perspective and tribute to the man behind the entity. Adv Anat Pathol 13: 286-292, 2006.
6. Dim DC, Cooley LD and Miranda RN: Clear cell sarcoma of tendons and aponeuroses: a review. Arch Pathol Lab Med 131: 152-156, 2007.
7. Miettinen M: From morphological to molecular diagnosis of soft tissue tumors. Adv Exp Med Biol 587: 99-113, 2006.
8. Fountoulakis M, Tsangaris G, Oh J, Maris A and Lubec G: Protein profile of the HeLa cell line. J Chrom A 1038: 247-265, 2004.
9. Berndt P, Hobohm U and Langen H: Reliable automatic protein identification from matrix-assisted laser desorption/ionization mass spectrometric peptide fingerprints. Electrophoresis 20: 3521-3526, 1999.
10. Watson CM, Johnston PG, Rodger KA, McKenzie LM, O'Neill RJ and Cooper DW: SRY and karyotypic status of one abnormal and two intersexual marsupials. Reprod Fertil Dev 9: 233-241, 1997.
11. Gelinas R, Yagi , Endlich B, Lotshaw C, Kazazian HH Jr and Stamatoyannopoulos G: Sequences of G gamma, A gamma, and beta genes of the Greek (A gamma) HPFH mutant: evidence for a distal CCAAT box mutation in the A gamma gene. Prog Clin Biol Res 191: 125-139, 1985.
12. Epstein AL, Martin AO and Kempson R: Use of a newly established human cell line (SU-CCS-1) to demonstrate the relationship of clear cell sarcoma to malignant melanoma. Cancer Res 44: 1265-1274, 1984.
13. Sonobe H, Furihata M, Iwata J, Ohtsuki Y, Mizobuchi H, Yamamoto H and Kumano O: Establishment and characterization of a new human clear cell sarcoma cell line, HS-MM. J Pathol 169: 317-322, 1993.
14. Takenouchi T, Ito K, Kazama T and Ito M: Establishment and characterization of a clear-cell sarcoma (malignant melanoma of soft parts) cell line. Arch Dermatol Res 286: 254-260, 1994.
15. Liao SK, Perng YP, Lee LA, Chang KSS, Lai GM, Wong E and Ho YS: Newly established MST-1 tumour cell line and tumour-infiltrating lymphocyte culture from a patient with soft tissue melanoma (clear cell sarcoma) and their potential applications to patient immunotherapy. Eur J Cancer 32A: 346-356, 1996.
16. Hiraga H, Nojima T, Abe S, Yamashiro K, Yamawaki S, Kaneda K and Nagashima K: Establishment of a new continuous clear cell sarcoma cell line. Virchows Arch 431: 45-51, 1997.
17. Chi A, Valencia JC, Hu ZZ, Watabe H, Yamaguchi H, Mangini NJ, Huang H, Canfield VA, Cheng KC, Yang F, Abe R, Yamagishi S, Shabanowitz J, Hearing VJ, Wu C, Appella E and Hunt D: Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes. J Proteome Res 5: 3135-3144, 2006.
18. Moritake H, Sugimoto T, Asada Y, Yoshida MA, Maehara Y, Epstein AL and Kuroda H: Newly established clear cell sarcoma (malignant melanoma of soft parts) cell line expressing melanoma-associated melan-A antigen and overexpressing C-MYC oncogene. Cancer Genet Cytogenet 135: 48-56, 2002.
19. Inozume T, Matsuzaki Y, Kurihara S, Fujita T, Yamamoto A, Aburatani H, Shimada S and Kawakami Y: Novel melanoma antigen, FCRL/FREB, identified by cDNA profile comparison using DNA chip are immunogenic in multiple melanoma patients. Int J Cancer 114: 283-290, 2005.
20. Granter SR, Weilbaecher KN, Quigley C, Fletcher CD and Fisher DE: Clear cell sarcoma shows immunoreactivity for microphthalmia transcription factor: further evidence for melanocytic differentiation. Mod Pathol 14: 6-9, 2001.
21. Ghosh AK, Majumder M, Steele R, White R and Ray RB: A novel 16-kiloDalton cellular protein physically interacts with and antagonizes the functional activity of c-myc promoter-binding protein 1. Mol Cell Biol 21: 655-662, 2001
22. Subramanian A and Miller DM: Structural analysis of alpha-enolase. Mapping the functional domains involved in down-regulation of the c-myc protooncogene. J Biol Chem 275: 5958-5965, 2000.
23. Kalaydjieva L, Gresham D, Gooding R, Heather L, Baas F, de Jonge R, Blechschmidt K, Angelicheva D, Chandler D, Worsley P, Rosenthal A, King RHM and Thomas P: N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom. Am J Hum Genet 67: 47-58, 2000.
24. Schaefer KL, Brachwit K, Wai DH, Braun Y, Diallo R, Korsching E, Eisenacher M, Voss R, van Valen F, Baer C, Selle B, Spahn L, Liao SK, Lee KAW, Hogendoorn PCW, Reifenberger G, Gabber HE and Poremba C: Expression profiling of t(12;22) positive clear cell sarcoma of soft tissue cell lines reveals characteristic up-regulation of potential new marker genes including ERBB3. Cancer Research 64: 3395-3405, 2004.
25. Lessor TJ and Hamburger AW: Regulation of the ErbB3 binding protein Ebpl by protein kinase C. Mol Cell Endocrinol 175: 185-191, 2001.
26. Obexer P, Geiger K, Ambros PF, Meister B and Ausserlechner MJ: FKHRLl-mediated expression of Noxa and Bim induces apoptosis via the mitochondria in neuroblastoma cells. Cell Death Differ 14: 534-547, 2007.
27. Schatton T, Murphy GF, Frank NY, Yamaura K, Waaga-Gasser AM, Gasser M, Zhan Q, Jordan S, Duncan LM, Weishaupt C, Fuhlbrigge RC, Kupper TS, Sayegh MH and Frank MH: Identification of cells initiating human melanomas. Nature 451: 345-349, 2008.
28. Keshet GI, Goldstein I, Itzhaki O, Cesarkas K, Shenhav L, Yakirevitch A, Treves AJ, Schachter J, Amariglio N and Rechavi G: MDR1 expression identifies human melanoma stem cells. Biochem Biophys Res Commun 368: 930-936, 2008.
29. Wiese C, Rolletschek A, Kania G, Blyszczuk P, Tarasov KV, Tarasova Y, Wersto RP, Boheler KR and Wobus AM: Nestin expression- a property of multi-lineage progenitor cells? Cell Mol Life Sci 61: 2510-2522, 2004.
30. Klein WM, Wu BP, Zhao S, Wu H, Klein-Szanto AJ and Tahan SR: Increased expression of stem cell markers in malignant melanoma. Mod Pathol 20: 102-107, 2007.
31. Satyamoorthy K, Meier F, Hsu MY, Berking C and Herlyn M: Human xenografts, human skin and skin reconstructs for studies in melanoma development and progression. Cancer Metastasis Rev 18: 401-405, 1999.